MLTX
Price
$20.41
Change
+$0.05 (+0.25%)
Updated
Jul 13 closing price
Capitalization
1.71B
30 days until earnings call
Intraday BUY SELL Signals
PRLD
Price
$4.44
Change
-$0.36 (-7.50%)
Updated
Jul 13 closing price
Capitalization
353.23M
37 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

MLTX vs PRLD

MLTX vs PRLD Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
MLTX vs. PRLD commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MLTX is a Buy and PRLD is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 14, 2026
Stock price -- (MLTX: $20.41 vs. PRLD: $4.44)
Brand notoriety: MLTX and PRLD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MLTX: 70% vs. PRLD: 41%
Market capitalization -- MLTX: $1.71B vs. PRLD: $353.23M
MLTX [@Biotechnology] is valued at $1.71B. PRLD’s [@Biotechnology] market capitalization is $353.23M. The market cap for tickers in the [@Biotechnology] industry ranges from $121.89B to $0. The average market capitalization across the [@Biotechnology] industry is $2.13B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MLTX’s FA Score shows that 0 FA rating(s) are green whilePRLD’s FA Score has 0 green FA rating(s).

  • MLTX’s FA Score: 0 green, 5 red.
  • PRLD’s FA Score: 0 green, 5 red.
According to our system of comparison, both MLTX and PRLD are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MLTX’s TA Score shows that 6 TA indicator(s) are bullish while PRLD’s TA Score has 3 bullish TA indicator(s).

  • MLTX’s TA Score: 6 bullish, 4 bearish.
  • PRLD’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, MLTX is a better buy in the short-term than PRLD.

Price Growth

MLTX (@Biotechnology) experienced а +8.10% price change this week, while PRLD (@Biotechnology) price change was -11.02% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.21%. For the same industry, the average monthly price growth was +7.25%, and the average quarterly price growth was +1806.27%.

Reported Earning Dates

MLTX is expected to report earnings on Aug 12, 2026.

PRLD is expected to report earnings on Aug 19, 2026.

Industries' Descriptions

@Biotechnology (-3.21% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MLTX($1.71B) has a higher market cap than PRLD($353M). MLTX (54.856) and PRLD (53.103) have similar YTD gains . PRLD has higher annual earnings (EBITDA): -82.47M vs. MLTX (-245.81M). MLTX has more cash in the bank: 358M vs. PRLD (81.6M). PRLD has less debt than MLTX: PRLD (17.7M) vs MLTX (101M). PRLD has higher revenues than MLTX: PRLD (16.7M) vs MLTX (0).
MLTXPRLDMLTX / PRLD
Capitalization1.71B353M483%
EBITDA-245.81M-82.47M298%
Gain YTD54.85653.103103%
P/E RatioN/AN/A-
Revenue016.7M-
Total Cash358M81.6M439%
Total Debt101M17.7M571%
TECHNICAL ANALYSIS
Technical Analysis
MLTXPRLD
RSI
ODDS (%)
Bearish Trend 4 days ago
61%
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
78%
Bearish Trend 4 days ago
88%
Momentum
ODDS (%)
Bullish Trend 4 days ago
68%
Bullish Trend 4 days ago
85%
MACD
ODDS (%)
Bearish Trend 4 days ago
63%
Bullish Trend 4 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
79%
Bearish Trend 4 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 4 days ago
90%
Advances
ODDS (%)
Bullish Trend 4 days ago
85%
N/A
Declines
ODDS (%)
Bearish Trend 12 days ago
77%
Bearish Trend 4 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
74%
Bearish Trend 4 days ago
88%
Aroon
ODDS (%)
Bullish Trend 4 days ago
84%
Bullish Trend 4 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
MLTX
Daily Signal:
Gain/Loss:
PRLD
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FCPCX30.19N/A
N/A
Fidelity Advisor Intl Cap App C
SSMHX384.11N/A
N/A
State Street Small/Mid Cap Equity Index
VEITX16.36N/A
N/A
VELA International I
ALOAX22.84N/A
N/A
Alger Mid Cap Focus A
APHSX42.53-0.83
-1.91%
Artisan Small Cap Institutional

MLTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MLTX has been closely correlated with KALA. These tickers have moved in lockstep 82% of the time. This A.I.-generated data suggests there is a high statistical probability that if MLTX jumps, then KALA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MLTX
1D Price
Change %
MLTX100%
+0.25%
KALA - MLTX
82%
Closely correlated
-7.23%
XNCR - MLTX
50%
Loosely correlated
-5.62%
NUVL - MLTX
48%
Loosely correlated
+0.03%
NRIX - MLTX
45%
Loosely correlated
-1.52%
XENE - MLTX
44%
Loosely correlated
-1.74%
More

PRLD and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRLD has been loosely correlated with NAUT. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if PRLD jumps, then NAUT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRLD
1D Price
Change %
PRLD100%
-7.60%
NAUT - PRLD
41%
Loosely correlated
-5.82%
MLTX - PRLD
35%
Loosely correlated
+0.25%
AMRN - PRLD
35%
Loosely correlated
-1.21%
AXON - PRLD
35%
Loosely correlated
-3.32%
KRRO - PRLD
34%
Loosely correlated
-7.28%
More